| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |